Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Completed · Phase 3 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

This is a Phase IIIb multicenter study to evaluate the safety and efficacy of certolizumab pegol (CZP) administered to patients with moderate-to-severe rheumatoid arthritis.

Key facts

Study ID

NCT00717236

Run by

UCB Pharma

People needed

1648

Starts

2008-07-01

Expected to finish

2011-03-01

Last updated by the study team

2018-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patient with established moderate to severe rheumatoid arthritis

You may not qualify if…

• All concomitant diseases or pathological conditions that could interfere and impact the assessment of the study treatment
• Previous clinical trials and previous biological therapy that could interfere with the results in the present clinical trials

Where it is running

• Study site — Montgomery, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Hot Springs, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Fullerton, California, United States
• Study site — La Jolla, California, United States
• Study site — Los Angeles, California, United States
• Study site — Palm Desert, California, United States
• Study site — Sacramento, California, United States
• Study site — Santa Barbara, California, United States
• Study site — Santa Maria, California, United States
• Study site — Tustin, California, United States
• Study site — Westlake Village, California, United States
• Study site — Whittier, California, United States
• Study site — Denver, Colorado, United States
• Study site — Danbury, Connecticut, United States
• Study site — Trumbull, Connecticut, United States
• Study site — Lewes, Delaware, United States
• Study site — Newark, Delaware, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Boca Raton, Florida, United States
• Study site — Delray Beach, Florida, United States
• Study site — Gainesville, Florida, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.